Enhanced Bioavailability
By dissolving directly into the mucosal membrane rather than surviving the GI tract, Instasolv is engineered to route actives around first-pass liver metabolism.
Phasys Delivery Platform
Meet Instasolv — Medicine’s Next Phase.
Powered by our proprietary Phasys technology, Instasolv transforms from solid to liquid at body temperature — reaching the bloodstream through the body’s own mucosal tissue, without a swallow, a needle, or a wait.
The Delivery Problem
Why the Delivery Mechanism Matters As Much As the Molecule
The best therapeutic in the world underperforms if it can’t reach the body intact, on time, and in a form the patient will actually take. Instasolv is built to solve the delivery half of that equation.
Precise, Controlled Release
Our Phasys polymer matrix is tunable — engineered for rapid onset or a sustained, controlled-release profile, depending on the clinical need.
Built-In Patient Compliance
No water. No swallowing. No injection. A format designed to remove the friction that causes patients to skip doses.
The Platform
One Technology. Three Delivery Formats.
Phasys is a single foundational polymer science — engineered by Ruyanic into three distinct Instasolv formats, each suited to a different physiological pathway.
Manufacturing
From Technology to Product
Instasolv formulations are manufactured through our partnership with an FDA-registered, cGMP-certified U.S. contract manufacturer, backed by over 15 years of pharmaceutical and polymer science expertise. Every Instasolv formulation moves from lab to scale under audit-ready quality systems — not a garage-stage promise.
Building the Next Generation of Drug Delivery — Together
We’re looking for pharmaceutical partners, biotech innovators, and investigators ready to put Instasolv to work on their next molecule.